Biotech Partners
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 494,911 | 651,572 | −156,661 | 12.1 | 53% |
| 2012 | 792,328 | 738,168 | 54,160 | 11.6 | 57% |
| 2013 | 468,894 | 686,705 | −217,811 | 8.6 | 55% |
| 2014 | 837,701 | 569,538 | 268,163 | 16.1 | 48% |
| 2015 | 374,303 | 693,676 | −319,373 | 7.7 | 55% |
| 2016 | 611,385 | 722,189 | −110,804 | 5.5 | 51% |
| 2017 | 416,812 | 689,041 | −272,229 | 0.7 | 54% |
| 2018 | 744,631 | 722,946 | 21,685 | 0.9 | 50% |
| 2019 | 791,200 | 694,906 | 96,294 | 2.6 | 47% |
| 2020 | 1,133,902 | 1,032,996 | 100,906 | 3.0 | 43% |
| 2021 | 988,215 | 1,082,364 | −94,149 | 1.8 | 43% |
| 2022 | 1,316,104 | 993,119 | 322,985 | 5.8 | 44% |
| 2023 | 1,658,822 | 1,102,639 | 556,183 | 11.3 | 47% |
In its most recent public year (2023), this organization brought in $556,183 more than it spent. Its reserves stood at about 11.3 months of spending. Staff pay was 47% of spending. $1,067,353 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Biotech Partners's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works